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~'7"3--3-] Thrombolysis After Resuscitation in Acute 
Myocardia l  Infarction 
Rudolf Schlale, J0rg Rustige, Udo Burczyk, Attain Koch, Dietdch Harmjenz, 
Ulrich Tebbe, Jochen Senges, for the ALKK Study Group. Herzzentmm 
Ludwigshalen, ZMBT Heidelberg; Germany 
Cardiopulmonary resuscitation (CPR) is often regarded as a relative con- 
tralndication to thrombelytlc therapy in AMI. We present results about the 
usage, safety and efficacy of iv@sis in CPR pts with AMI. "The 60-Minutes 
Myocardial Infarction Project" is an open German multicenter study, which 
registered all transmural AMI in 136 hospitals prospectively over 27 months. 
From a total of 14.980 AMI, 681 pts (4.5°/=) received CPR with chest com- 
pressions (mean age 64 4-13 yrs, 73% male, 53% anterior wall MI). 
Results: 45% of all CPR pte received iv-thrombolysis. CPR pts with lysla 
had a lower intrahospital mortality, despite more bleeding complications. In 
a multivariate analysis adjusting for 14 risk factors (including age), tysis was 
independently associated with a lower mortality (odds ratio 0.6, 95%-CI 0,4- 
0.9), except for the subgroup of pts with a left bundle branch block (12%), 
who did not benefit from tysis (OR 3.7, 95%-CI 0.9-15). 
CPR ht AMI All CPR Lysla No tysis p 
(n = 6B1) (n = 308) (n - 373) 
Hospllal mortality 56% 48% 62% <0.001 
Hemorrhage & transfusion 3.4% 6.5% 0.8% <0.001 
Conclusions: The outcome in nonrandomized CPR pts with AMI receiving 
thrombelysis is better despite more bleeding complications, The improved 
outcome is most likely a lysis effect, not only a selection bias. 
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~ Predictom of  Artery la tency Maintained Infarct After 
Primary Angloplesty in High Risk Patients In PAMI-2 
Keith H. Benzuly, William W. O'Neill, Bruce Brodie, John Griffin, 
Thomas Shimshak, Denise E. Jones, Madann Graham, Uoudmfla Mitina, 
Cindy L Grines. William Beaumont Hospital, Royal Oak, Michigan 
Sustaloed ropadusion is an important predictor of long term prognosis follow- 
ing acute MI. To determine predictors of sustained infarct artery (IRA) patency 
after primary PTCA, we performed a blinded core lab analysis of 298 high 
risk pts who underwent protocol re-catheterizatior~ prior to discharge in the 
PAMI-2 study. Pdmary PTCA was successful (IRA < 50°/= residual stenosis 
end TIMI 2-3 flow) in 95.8% of high-risk patients. 
ReCath TIMI flow P-value 
0-1 (n = 27) 2-3 (n = 271 )
ASA at home (%) 19.2 21.8 0.76 
Prior MI (%) 4.0 21.8 0.04 
MuItbessel Disease (%) 40.7 52.0 0.26 
Right coronary PTCA (%) 40.7 32.8 0.41 
Balloon Size (mm) 3.11 :t: 0.45 3.08 :t: 0.46 0.73 
Post PICA TIMI-3 (%) 92.6 90.8 0.75 
Residue1Stsnosls (mt'~n) 9.5.9 :E 18.3 22.7 ~ 11.9 0.38 
Post PTCA Dissection !%) 48.2 24.6 (N = 264) 0.009 
Acute eje~. ion fraction, infarct zone wall motion, presence of thrombus, 
use of lytlcs ov balloon pump, age, diabetes, smoking, hypertension and 
hyperlipldemia were not predictive of TIMI flow at recath. 
Conclusion: Absence of prior myocardial infarction or the presence of 
dissection following PTCA in high risk MI pte is predictive of rcocclusion on the 
pre-discharge angiogram. Aggressive treatment of dissection complicating 
PTCA of acute MI may improve outcome. 
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~';73---'~ Antlplatelet vs, Antlcoagulat lon Treatment Alter 
Intracoronsry Palmaz-Schetz Stent Pla~emest in 
Acute Myocardial Infarction ~ A Prospective 
Randomized TrIM 
Hanna Walter, Franz-Josef Neumann, Gert Richardt, Eckhan:l Aft, 
Claus Schmitt, Rudolf Blesioi, Helmut SchQhlan, Marlin Hadamiizky, 
Eva Zdzmann, Albert Sch0mlg. 1. Medizinische Klinik, Klinikum rechts der 
Isar, Technische Univeralt~f Munich, Germany 
A recent study has demonstrated the feasibility and safety of intracoronary 
stent placement in acute myocardial infarction (AMI). Aim of our study was 
the comparison of two different antithrombetio regiments after stesting In AMI. 
Within a prospective randomized trial an anticoagulalion pmtocel (espldn 100 
mg btd+ phenprocoumon I.v.-heparin until a target INR of 3.5) was compared 
with an antiplatatst protocol (aspirin 100 mg bid + ticlopldine 250 mg bid). 
Between October 1, 1994, and August 31, 1995, 105 randomized patients 
had slant placement in uncomplicated AMI. Patients with cardiugenio shock 
or the need of mechanical ventilation were excluded from randomlaaticn. So 
far 54 patients are randomized for anticoagulation, 51 for antiplatelat protocol. 
The randomization will be completed October 1,1995. Cardiac events (death, 
myocardial minfarction, stant occlusion, CABG, repeat PTCA) and bleeding 
events requiring transfusion or surgery, or impairing organ function, and local 
groin complications are assessed. Reangiography is performed two weeks 
and 6 months after the intervention. Angiographio data are evaluated by an 
automated edge detection method. 
Analysis of the two treatment groups for clinical events and engiugraphic 
outcome during a 30 day and 6 month follow up period will be presented. 
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~ ' ~  Stsntlng for Acute Myocardial Infarction: The Earty 
United States Mull icenter Experience 
Steven R. Steinhubl, David J. Molitemo, Paul S. Teirstein, Erminia 
M. Guameri, Frank V. Aguirre, James J. Fergucon, Emerson C. Perin, 
Nell Strickman, Dean Kerelakes. James E. Tcheng, Stevan G. Ellis, Eric 
J. Topoi. The Cleveland Clinic Fou~n,  C;eveland, OH 
Plaque fissuring and rupture, with resultant thrombosis, is the etiology of 
acute MI in nearly all patients with ST elevation. Primary and rescue an- 
gioplasty of the infarct-related i~rtery not infreqt,ently results in a localized 
or propagated intimal dissection, and in come patL=,~, ts rethrombesla of tho 
vessel. Empirically, slanting was thought to be contrai;x, cated fur acute MI 
because of the propensity for thrombosis. 
Methods: With contemporary opLimal slant deployment techniques, whicd 
appear to reduce subanute thrombosis in elective intewentions, thla app!ica- 
tion in acute MI was explored at 6 U.S. centare involving 44 patients. 
Resu~: Direct intervention was performed in 68% of patients and as 
rescue after failed thrombotysLs in 32%. Slants were placed seconda~ to 
dissection in 76=, sub-optimal results in 19% and as pdmary treatment in 
5%. More than 1 stent was placed in 27%. The mfemge vessel size was 
3.22 ram, and the average maximal inflation pressure was 13.8 arm. Pert- 
procedural medications included heparin (100°/=), aspirin (100%), urokinase 
(27%), ReoPm (19%), T'clid (19°/,) and Persantine (5%). Initial procedural 
success rate was 95%. 30-day outcome included 2% re-PTCA, 5% CABG 
a,'~d 7"/, morLali~. Tv,~O of these adverse outcomes (4.5% of total cohort) were 
secondary to subacuta stent thrombosis. 
Conclusion: Using current optimal stent deployment techniques with anti- 
platelet and anti-thrombotic therapy, intracoronary slants are a promising 
therapy in evolving MI. True dsk and cost-benerd assessment will require 
prospective randomized trials. 
Calcium Antagonist Therapy in Heart Failure 
Wednesday,  March 27, 1996, 8:30 a.m.-10:00 a.m. 
Orange County Convent ion Center, Room 222 
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I " ~  Long-Term Calcium-Channel Blockade Causes Left 
Ventricular Dilation in Asymptomatic Patients With 
Chronic Infarction 
Petor Gaudmn, Ingdd Kugter, Kai Hu, C. Eilles 1, Georg Ertl. Departmanfof 
Medicine II Mannheim, University of Heidelberg; 1Regeosburg, Germany 
Calciumchannel t~l~ker (CCB) may precipitate adveme events in patients 
with severe left ventdcular (LV) dysfunction after myocardial infarction (Mi). LV 
dilation precedes LV dysfunction and is an independent predictor of adveme 
events and mortality in patients after ML We tested that the new-generation 
CCB niscldipine (Ntso), a potent vacodilatsr, may prevent LV dilation (remod- 
eling) after mild asymptomatic LV-dysfunction following moderate ML In a 
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